Dual role of toll-like receptors in asthma and chronic obstructive pulmonary disease

Pharmacological Reviews

Volumn 64, Issue 2, 2012, Pages 337-358

  Bezemer, Gillina F G ^a   Sagar, Seil ^b   van Bergenhenegouwen, Jeroen ^b   Georgiou, Niki A ^b   Garssen, Johan ^b   Kraneveld, Aletta D ^a   Folkerts, Gert ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b DANONE RESEARCH   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ANTIBIOTIC AGENT; CIGARETTE SMOKE; CPG OLIGODEOXYNUCLEOTIDE; GAMMA INTERFERON; GLUTATHIONE TRANSFERASE; HEME OXYGENASE 1; IMMUNOGLOBULIN E; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 8; PATTERN RECOGNITION RECEPTOR; PROTEIN S 100; SERINE; SUPEROXIDE DISMUTASE; THYMIC STROMAL LYMPHOPOIETIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 11; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 9;

ADAPTIVE IMMUNITY; ASTHMA; BLOOD OXYGEN TENSION; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE EXACERBATION; DYSPNEA; ENVIRONMENTAL FACTOR; GENE EXPRESSION; GENE FREQUENCY; GENETIC VARIABILITY; HAEMOPHILUS INFLUENZAE; HUMAN; IMMUNOMODULATION; INNATE IMMUNITY; LEUKOCYTE ACTIVATION; LUNG INFECTION; MAST CELL; NONHUMAN; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SUBLINGUAL IMMUNOTHERAPY; SYMPTOM;

AGE FACTORS; AGED; ANIMALS; ASTHMA; CHILD; CHILD, PRESCHOOL; DRUG DELIVERY SYSTEMS; DRUG DESIGN; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; TOLL-LIKE RECEPTORS;

EID: 84858197367     PISSN: 00316997     EISSN: 15210081     Source Type: Journal    
DOI: 10.1124/pr.111.004622     Document Type: Review

References (296)

1. Agustí AG, Noguera A, Sauleda J, Sala E, Pons J, and Busquets X (2003) Systemic effects of chronic obstructive pulmonary disease. Eur Respir J 21:347-360.
2. Akira S (2003) Toll-like receptor signaling. J Biol Chem 278:38105-38108.
3. Akira S and Takeda K (2004) Toll-like receptor signalling. Nat Rev Immunol 4:499-511.
4. Anderson HR, Spix C, Medina S, Schouten JP, Castellsague J, Rossi G, Zmirou D, Touloumi G, Wojtyniak B, Ponka A, et al. (1997) Air pollution and daily admissions for chronic obstructive pulmonary disease in 6 European cities: results from the APHEA project. Eur Respir J 10:1064-1071.
5. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, and Seed B (1990) CD44 is the principal cell surface receptor for hyaluronate. Cell 61:1303-1313.
6. Asea A (2008) Heat shock proteins and toll-like receptors. Handb Exp Pharmacol (183):111-127.
7. Bailey KL, Poole JA, Mathisen TL, Wyatt TA, Von Essen SG, and Romberger DJ (2008) Toll-like receptor 2 is upregulated by hog confinement dust in an IL-6-dependent manner in the airway epithelium. Am J Physiol Lung Cell Mol Physiol 294:L1049-L1054.
8. Barnes PJ (2004a) Alveolar macrophages as orchestrators of COPD. COPD 1:59-70.
9. Barnes PJ (2004b) Mediators of chronic obstructive pulmonary disease. Pharmacol Rev 56:515-548.
10. Barnes PJ (2008a) Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol 8:183-192.
11. Barnes PJ (2008b) The cytokine network in asthma and chronic obstructive pulmonary disease. J Clin Invest 118:3546-3556.
12. Barnes PJ (2010) New therapies for asthma: is there any progress? Trends Pharmacol Sci 31:335-343.
13. Barnes PJ and Celli BR (2009) Systemic manifestations and comorbidities of COPD. Eur Respir J 33:1165-1185.
14. Basith S, Manavalan B, Lee G, Kim SG, and Choi S (2011) Toll-like receptor modulators: a patent review (2006-2010). Expert Opin Ther Pat 21:927-944.
15. Beasley R, Crane J, Lai CK, and Pearce N (2000) Prevalence and etiology of asthma. J Allergy Clin Immunol 105:S466-S472.
16. Bezemer GF, Bauer SM, Oberdörster G, Breysse PN, Pieters RH, Georas SN, and Williams MA (2011) Activation of pulmonary dendritic cells and Th2-type inflammatory responses on instillation of engineered, environmental diesel emission source or ambient air pollutant particles in vivo. J Innate Immun 3:150-166.
17. Bianchi ME (2007) DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 81:1-5.
18. Bianchi ME (2009) HMGB1 loves company. J Leukoc Biol 86:573-576.
19. Björkstén B, Naaber P, Sepp E, and Mikelsaar M (1999) The intestinal microflora in allergic Estonian and Swedish 2-year-old children. Clin Exp Allergy 29:342-346.
20. Björkstén B, Sepp E, Julge K, Voor T, and Mikelsaar M (2001) Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol 108:516-520.
21. Bollyky PL, Falk BA, Wu RP, Buckner JH, Wight TN, and Nepom GT (2009) Intact extracellular matrix and the maintenance of immune tolerance: high molecular weight hyaluronan promotes persistence of induced CD4+CD25+ regulatory T cells. J Leukoc Biol 86:567-572.
22. Bollyky PL, Lord JD, Masewicz SA, Evanko SP, Buckner JH, Wight TN, and Nepom GT (2007) Cutting edge: high molecular weight hyaluronan promotes the suppressive effects of CD4+CD25+ regulatory T cells. J Immunol 179:744-747.
23. Bracke KR, Dentener MA, Papakonstantinou E, Vernooy JH, Demoor T, Pauwels NS, Cleutjens J, van Suylen RJ, Joos GF, Brusselle GG, et al. (2010) Enhanced deposition of low-molecular-weight hyaluronan in lungs of cigarette smokeexposed mice. Am J Respir Cell Mol Biol 42:753-761.
24. Broide DH (2009) Immunomodulation of allergic disease. Annu Rev Med 60:279-291.
25. Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, Menezes AM, Sullivan SD, Lee TA, Weiss KB, et al., and BOLD Collaborative Research Group (2007) International variation in the prevalence of COPD (the BOLD study): a population-based prevalence study. Lancet 370:741-750.
26. Camateros P, Tamaoka M, Hassan M, Marino R, Moisan J, Marion D, Guiot MC, Martin JG, and Radzioch D (2007) Chronic asthma-induced airway remodeling is prevented by toll-like receptor-7/8 ligand S28463. Am J Respir Crit Care Med 175:1241-1249.
27. Campbell JD, Cho Y, Foster ML, Kanzler H, Kachura MA, Lum JA, Ratcliffe MJ, Sathe A, Leishman AJ, Bahl A, et al. (2009) CPG-containing immunostimulatory DNA sequences elicit TNF-alpha-dependent toxicity in rodents but not in humans. J Clin Invest 119:2564-2576.
28. Carta S, Castellani P, Delfino L, Tassi S, Venè R, and Rubartelli A (2009) DAMPs and inflammatory processes: the role of redox in the different outcomes. J Leukoc Biol 86:549-555.
29. Charlton SJ (2009) Agonist efficacy and receptor desensitization: from partial truths to a fuller picture. Br J Pharmacol 158:165-168.
30. Chaudhuri N, Dower SK, Whyte MK, and Sabroe I (2005) Toll-like receptors and chronic lung disease. Clin Sci 109:125-133.
31. Chaudhuri N, Paiva C, Donaldson K, Duffin R, Parker LC, and Sabroe I (2010) Diesel exhaust particles override natural injury-limiting pathways in the lung. Am J Physiol Lung Cell Mol Physiol 299:L263-L271.
32. Chaudhuri N, Whyte MK, and Sabroe I (2007) Reducing the toll of inflammatory lung disease. Chest 131:1550-1556.
33. Chelen CJ, Fang Y, Freeman GJ, Secrist H, Marshall JD, Hwang PT, Frankel LR, DeKruyff RH, and Umetsu DT (1995) Human alveolar macrophages present antigen ineffectively due to defective expression of B7 costimulatory cell surface molecules. J Clin Invest 95:1415-1421.
34. Chen L, Arora M, Yarlagadda M, Oriss TB, Krishnamoorthy N, Ray A, and Ray P (2006) Distinct responses of lung and spleen dendritic cells to the TLR9 agonist CpG oligodeoxynucleotide. J Immunol 177:2373-2383.
35. Chu RS, Targoni OS, Krieg AM, Lehmann PV, and Harding CV (1997) CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J Exp Med 186:1623-1631.
36. Cognasse F, Hamzeh H, Chavarin P, Acquart S, Genin C, and Garraud O (2005) Evidence of Toll-like receptor molecules on human platelets. Immunol Cell Biol 83:196-198.
37. Cosmi L, Liotta F, Maggi E, Romagnani S, and Annunziato F (2011) Th17 cells: new players in asthma pathogenesis. Allergy 66:989-998.
38. Creticos PS, Schroeder JT, Hamilton RG, Balcer-Whaley SL, Khattignavong AP, Lindblad R, Li H, Coffman R, Seyfert V, Eiden JJ, et al., and Immune Tolerance Network Group (2006) Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis. N Engl J Med 355:1445-1455.
39. Davis HL (2000) Use of CpG DNA for enhancing specific immune responses. Curr Top Microbiol Immunol 247:171-183.
40. de Haar C, Hassing I, Bol M, Bleumink R, and Pieters R (2006) Ultrafine but not fine particulate matter causes airway inflammation and allergic airway sensitization to co-administered antigen in mice. Clin Exp Allergy 36:1469-1479.
41. de Marco R, Accordini S, Marcon A, Cerveri I, Antó JM, Gislason T, Heinrich J, Janson C, Jarvis D, Kuenzli N, et al., and European Community Respiratory Health Survey (ECRHS) (2011) Risk factors for chronic obstructive pulmonary disease in a European cohort of young adults. Am J Respir Crit Care Med 183: 891-897.
42. de Roock S, van Elk M, van Dijk ME, Timmerman HM, Rijkers GT, Prakken BJ, Hoekstra MO, and de Kleer IM (2010) Lactic acid bacteria differ in their ability to induce functional regulatory T cells in humans. Clin Exp Allergy 40:103-110.
43. Dentener MA, Vernooy JH, Hendriks S, and Wouters EF (2005) Enhanced levels of hyaluronan in lungs of patients with COPD: relationship with lung function and local inflammation. Thorax 60:114-119.
44. Devenny A, Wassall H, Ninan T, Omran M, Khan SD, and Russell G (2004) Respiratory symptoms and atopy in children in Aberdeen: questionnaire studies of a defined school population repeated over 35 years. BMJ 329:489-490.
45. Devereux G (2006) The increase in the prevalence of asthma and allergy: food for thought. Nat Rev Immunol 6:869-874.
46. Diamant Z and Spina D (2011) PDE4-inhibitors: a novel, targeted therapy for obstructive airways disease. Pulm Pharmacol Ther 24:353-360.
47. Díaz E, Bruce N, Pope D, Lie RT, Díaz A, Arana B, Smith KR, and Smith-Sivertsen T (2007) Lung function and symptoms among indigenous Mayan women exposed to high levels of indoor air pollution. Int J Tuberc Lung Dis 11:1372-1379.
48. Dirven JA, Muris JW, and van Schayck CP (2010) COPD screening in general practice using a telephone questionnaire. COPD 7:352-359.
49. Donaldson GC, Seemungal TA, Bhowmik A, and Wedzicha JA (2002) Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 57:847-852.
50. Dong L, Li H, Wang S, and Li Y (2009) Different doses of lipopolysaccharides regulate the lung inflammation of asthmatic mice via TLR4 pathway in alveolar macrophages. J Asthma 46:229-233.
51. Donnelly LE and Rogers DF (2003) Therapy for chronic obstructive pulmonary disease in the 21st century. Drugs 63:1973-1998.
52. Drexler SK and Foxwell BM (2010) The role of toll-like receptors in chronic inflammation. Int J Biochem Cell Biol 42:506-518.
53. Droemann D, Goldmann T, Tiedje T, Zabel P, Dalhoff K, and Schaaf B (2005) Toll-like receptor 2 expression is decreased on alveolar macrophages in cigarette smokers and COPD patients. Respir Res 6:68.
54. Eddleston J, Lee RU, Doerner AM, Herschbach J, and Zuraw BL (2011) Cigarette smoke decreases the innate responses of epithelial cells to rhinovirus infection. Am J Respir Cell Mol Biol 44:118-126.
55. Ehrchen JM, Sunderkötter C, Foell D, Vogl T, and Roth J (2009) The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. J Leukoc Biol 86:557-566.
56. Erb-Downward JR, Thompson DL, Han MK, Freeman CM, McCloskey L, Schmidt LA, Young VB, Toews GB, Curtis JL, Sundaram B, et al. (2011) Analysis of the lung microbiome in the "healthy" smoker and in COPD. PLoS One 6:e16384.
57. Erridge C (2010) Endogenous ligands of TLR2 and TLR4: agonists or assistants? J Leukoc Biol 87:989-999.
58. Fang H, Wu Y, Huang X, Wang W, Ang B, Cao X, and Wan T (2011) Toll-like receptor 4 (TLR4) is essential for Hsp70-like protein 1 (HSP70L1) to activate dendritic cells and induce Th1 response. J Biol Chem 286:30393-30400.
59. Feleszko W, Jaworska J, and Hamelmann E (2006) Toll-like receptors-novel targets in allergic airway disease (probiotics, friends and relatives). Eur J Pharmacol 533:308-318.
60. Ferhani N, Letuve S, Kozhich A, Thibaudeau O, Grandsaigne M, Maret M, Dombret MC, Sims GP, Kolbeck R, Coyle AJ, et al. (2010) Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 181:917-927.
61. Fink LN (2010) Induction of regulatory T cells by probiotics: potential for treatment of allergy? Clin Exp Allergy 40:5-8.
62. Foell D, Wittkowski H, Vogl T, and Roth J (2007) S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J Leukoc Biol 81:28-37.
63. Fonseca DE and Kline JN (2009) Use of CpG oligonucleotides in treatment of asthma and allergic disease. Adv Drug Deliv Rev 61:256-262.
64. Forsythe P, Inman MD, and Bienenstock J (2007) Oral treatment with live Lactobacillus reuteri inhibits the allergic airway response in mice. Am J Respir Crit Care Med 175:561-569.
65. Frew AJ (1996) The immunology of respiratory allergies. Toxicol Lett 86:65-72.
66. Friedberg JW, Kelly JL, Neuberg D, Peterson DR, Kutok JL, Salloum R, Brenn T, Fisher DC, Ronan E, Dalton V, et al. (2009) Phase II study of a TLR-9 agonist (1018 ISS) with rituximab in patients with relapsed or refractory follicular lymphoma. Br J Haematol 146:282-291.
67. Fuchs B and Braun A (2008) Modulation of asthma and allergy by addressing toll-like receptor 2. J Occup Med Toxicol 3 (Suppl 1):S5.
68. Fuchs B, Knothe S, Rochlitzer S, Nassimi M, Greweling M, Lauenstein HD, Nassenstein C, Müller M, Ebensen T, Dittrich AM, et al. (2010) A Toll-like receptor 2/6 agonist reduces allergic airway inflammation in chronic respiratory sensitization to Timothy grass pollen antigens. Int Arch Allergy Immunol 152:131-139.
69. Gamble J, Stevenson M, McClean E, and Heaney LG (2009) The prevalence of nonadherence in difficult asthma. Am J Respir Crit Care Med 180:817-822.
70. Gan WQ, Man SF, Senthilselvan A, and Sin DD (2004) Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 59:574-580.
71. Gauvreau GM, Hessel EM, Boulet LP, Coffman RL, and O'Byrne PM (2006) Immunostimulatory sequences regulate interferon-inducible genes but not allergic airway responses. Am J Respir Crit Care Med 174:15-20.
72. Gibson PG, Simpson JL, and Saltos N (2001) Heterogeneity of airway inflammation in persistent asthma: evidence of neutrophilic inflammation and increased sputum interleukin-8. Chest 119:1329-1336.
73. Goldman M (2008) Sublingual immunotherapy: the quest for innovative adjuvants. Clin Exp Allergy 38:1705-1706.
74. Gooptu B, Ekeowa UI, and Lomas DA (2009) Mechanisms of emphysema in alpha1-antitrypsin deficiency: molecular and cellular insights. Eur Respir J 34:475-488.
75. Greene CM and McElvaney NG (2005) Toll-like receptor expression and function in airway epithelial cells. Arch Immunol Ther Exp (Warsz) 53:418-427.
76. Hacker S, Lambers C, Hoetzenecker K, Pollreisz A, Aigner C, Lichtenauer M, Mangold A, Niederpold T, Zimmermann M, Taghavi S, et al. (2009) Elevated HSP27, HSP70 and HSP90 alpha in chronic obstructive pulmonary disease: markers for immune activation and tissue destruction. Clin Lab 55:31-40.
77. Hammad H, Chieppa M, Perros F, Willart MA, Germain RN, and Lambrecht BN (2009) House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells. Nat Med 15:410-416.
78. Hammad H, Lambrecht BN, Pochard P, Gosset P, Marquillies P, Tonnel AB, and Pestel J (2002) Monocyte-derived dendritic cells induce a house dust mite-specific Th2 allergic inflammation in the lung of humanized SCID mice: involvement of CCR7. J Immunol 169:1524-1534.
79. Hart JE, Laden F, Schenker MB, and Garshick E (2006) Chronic obstructive pulmonary disease mortality in diesel-exposed railroad workers. Environmental Health Perspectives 114:1013-1017.
80. Hartl FU and Hayer-Hartl M (2002) Molecular chaperones in the cytosol: from nascent chain to folded protein. Science 295:1852-1858.
81. Hasan U, Chaffois C, Gaillard C, Saulnier V, Merck E, Tancredi S, Guiet C, Brière F, Vlach J, Lebecque S, et al. (2005) Human TLR10 is a functional receptor, expressed by B cells and plasmacytoid dendritic cells, which activates gene transcription through MyD88. J Immunol 174:2942-2950.
82. Hasday JD, Bascom R, Costa JJ, Fitzgerald T, and Dubin W (1999) Bacterial endotoxin is an active component of cigarette smoke. Chest 115:829-835.
83. Hashimoto C, Hudson KL, and Anderson KV (1988) The Toll gene of Drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein. Cell 52:269-279.
84. Hayashi T and Raz E (2006) TLR9-based immunotherapy for allergic disease. Am J Med 119:897.e1-897.e6.
85. Heijink IH and Van Oosterhout AJ (2006) Strategies for targeting T-cells in allergic diseases and asthma. Pharmacol Ther 112:489-500.
86. Hines C (2002) The diverse effects of mast cell mediators. Clin Rev Allergy Immunol 22:149-160.
87. Hodge G, Nairn J, Holmes M, Reynolds PN, and Hodge S (2007a) Increased intracellular T helper 1 proinflammatory cytokine production in peripheral blood, bronchoalveolar lavage and intraepithelial T cells of COPD subjects. Clin Exp Immunol 150:22-29.
88. Hodge S, Hodge G, Ahern J, Jersmann H, Holmes M, and Reynolds PN (2007b) Smoking alters alveolar macrophage recognition and phagocytic ability: implications in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 37:748-755.
89. Hodge S, Hodge G, Scicchitano R, Reynolds PN, and Holmes M (2003) Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability to phagocytose apoptotic airway epithelial cells. Immunol Cell Biol 81:289-296.
90. Hoffjan S, Stemmler S, Parwez Q, Petrasch-Parwez E, Arinir U, Rohde G, Reinitz-Rademacher K, Schultze-Werninghaus G, Bufe A, and Epplen JT (2005) Evaluation of the toll-like receptor 6 Ser249Pro polymorphism in patients with asthma, atopic dermatitis and chronic obstructive pulmonary disease. BMC Med Genet 6:34.
91. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, et al. (2004) The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 350:2645-2653.
92. Hollingsworth JW, Maruoka S, Li Z, Potts EN, Brass DM, Garantziotis S, Fong A, Foster WM, and Schwartz DA (2007) Ambient ozone primes pulmonary innate immunity in mice. J Immunol 179:4367-4375.
93. Hong HJ, Kim E, Cho D, and Kim TS (2010) Differential suppression of heat-killed lactobacilli isolated from kimchi, a Korean traditional food, on airway hyperresponsiveness in mice. J Clin Immunol 30:449-458.
94. Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdörfer B, Giese T, Endres S, and Hartmann G (2002) Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 168:4531-4537.
95. Hou C, Zhao H, Li W, Liang Z, Zhang D, Liu L, Tong W, Cai SX, and Zou F (2011) Increased heat shock protein 70 levels in induced sputum and plasma correlate with severity of asthma patients [published erratum appears in Cell Stress Chaperones 16:673, 2011]. Cell Stress Chaperones 16:663-671.
96. Hussain I and Kline JN (2001) CpG oligodeoxynucleotides in asthma. Curr Opin Investig Drugs 2:914-918.
97. Ikeda K, Bell JP, Aoki M, Nakayama T, Eiho K, Onishi M, Takaku H, Nishikaku F (2010) AZD8848/DSP-3025, a novel TLR7 agonist ante-drug, demonstrates efficacy against airway obstruction and other inflammatory endpoints in guinea pig models of rhinitis and asthma with acute and weekly dosing. Am J Respir Crit Care Med 181:A4242.
98. Inoue K, Takano H, Yanagisawa R, Hirano S, Ichinose T, Shimada A, and Yoshikawa T (2006) The role of toll-like receptor 4 in airway inflammation induced by diesel exhaust particles. Arch Toxicol 80:275-279.
99. Into T, Dohkan J, Inomata M, Nakashima M, Shibata K, and Matsushita K (2007) Synthesis and characterization of a dipalmitoylated lipopeptide derived from paralogous lipoproteins of Mycoplasma pneumoniae. Infect Immun 75:2253-2259.
100. ISAAC Steering Committee (1998) Worldwide variations in the prevalence of asthma symptoms: the International Study of Asthma and Allergies in Childhood (ISAAC). Eur Respir J 12:315-335.
101. Janson C, Kalm-Stephens P, Foucard T, Alving K, and Nordvall SL (2007) Risk factors associated with allergic and non-allergic asthma in adolescents. Clin Respir J 1:16-22.
102. Jarnicki AG, Conroy H, Brereton C, Donnelly G, Toomey D, Walsh K, Sweeney C, Leavy O, Fletcher J, Lavelle EC, et al. (2008) Attenuating regulatory T cell induction by TLR agonists through inhibition of p38 MAPK signaling in dendritic cells enhances their efficacy as vaccine adjuvants and cancer immunotherapeutics. J Immunol 180:3797-3806.
103. Jiang D, Liang J, and Noble PW (2007) Hyaluronan in tissue injury and repair. Annu Rev Cell Dev Biol 23:435-461.
104. Jiang D, Liang J, Fan J, Yu S, Chen S, Luo Y, Prestwich GD, Mascarenhas MM, Garg HG, Quinn DA, et al. (2005) Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med 11:1173-1179.
105. Juarez E, Nuñez C, Sada E, Ellner JJ, Schwander SK, and Torres M (2010) Differential expression of Toll-like receptors on human alveolar macrophages and autologous peripheral monocytes. Respir Res 11:2.
106. Kaisho T and Akira S (2006) Toll-like receptor function and signaling. J Allergy Clin Immunol 117:979-987.
107. Kalliomäki M, Antoine JM, Herz U, Rijkers GT, Wells JM, and Mercenier A (2010) Guidance for substantiating the evidence for beneficial effects of probiotics: prevention and management of allergic diseases by probiotics. J Nutr 140:713S-721S.
108. Kalliomäki M, Kirjavainen P, Eerola E, Kero P, Salminen S, and Isolauri E (2001) Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol 107:129-134.
109. Kambayashi T, Larosa DF, Silverman MA, and Koretzky GA (2009) Cooperation of adapter molecules in proximal signaling cascades during allergic inflammation. Immunol Rev 232:99-114.
110. Karimi K, Sarir H, Mortaz E, Smit JJ, Hosseini H, De Kimpe SJ, Nijkamp FP, and Folkerts G (2006) Toll-like receptor-4 mediates cigarette smoke-induced cytokine production by human macrophages. Respir Res 7:66.
111. Kasahara Y, Tuder RM, Cool CD, Lynch DA, Flores SC, and Voelkel NF (2001) Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am J Respir Crit Care Med 163:737-744.
112. Kawana H, Karaki H, Higashi M, Miyazaki M, Hilberg F, Kitagawa M, and Harigaya K (2008) CD44 suppresses TLR-mediated inflammation. J Immunol 180:4235-4245.
113. Kim EY, Battaile JT, Patel AC, You Y, Agapov E, Grayson MH, Benoit LA, Byers DE, Alevy Y, Tucker J, et al. (2008) Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease. Nat Med 14:633-640.
114. King ME, Mannino DM, and Holguin F (2004) Risk factors for asthma incidence. A review of recent prospective evidence. Panminerva Medica 46:97-110.
115. Kline JN (2007) Eat dirt: CpG DNA and immunomodulation of asthma. Proc Am Thorac Soc 4:283-288.
116. Kline JN and Krieg AM (2008) Toll-like receptor 9 activation with CpG oligodeoxynucleotides for asthma therapy. Drug News Perspect 21:434-439.
117. Klinman DM, Yi AK, Beaucage SL, Conover J, and Krieg AM (1996) CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. Proc Natl Acad Sci USA 93:2879-2883.
118. Knudsen TB, Thomsen SF, Nolte H, and Backer V (2009) A population-based clinical study of allergic and non-allergic asthma. J Asthma 46:91-94.
119. Knuefermann P, Baumgarten G, Koch A, Schwederski M, Velten M, Ehrentraut H, Mersmann J, Meyer R, Hoeft A, Zacharowski K, et al. (2007) CpG oligonucleotide activates Toll-like receptor 9 and causes lung inflammation in vivo. Respir Res 8:72.
120. Kobayashi M, Kubo S, Iwata M, Ohtsu Y, Takahashi K, and Shimizu Y (2011) ASP3258, an orally active potent phosphodiesterase 4 inhibitor with low emetic activity. Int Immunopharmacol 11:732-739.
121. Kogevinas M, Antó JM, Sunyer J, Tobias A, Kromhout H, and Burney P (1999) Occupational asthma in Europe and other industrialised areas: a population-based study. European Community Respiratory Health Survey Study Group. Lancet 353:1750-1754.
122. Koller B, Bals R, Roos D, Korting HC, Griese M, and Hartl D (2009) Innate immune receptors on neutrophils and their role in chronic lung disease. Eur J Clin Invest 39:535-547.
123. Koning CJ, Jonkers D, Smidt H, Rombouts F, Pennings HJ, Wouters E, Stobberingh E, and Stockbrügger R (2010) The effect of a multispecies probiotic on the composition of the faecal microbiota and bowel habits in chronic obstructive pulmonary disease patients treated with antibiotics. Br J Nutr 103:1452-1460.
124. Kono H and Rock KL (2008) How dying cells alert the immune system to danger. Nat Rev Immunol 8:279-289.
125. Konopka Ł, Wierzbicki M, and Brzeziń ska-Błaszczyk E (2010) Lipopolysaccharide from Porphyromonas gingivalis stimulates rat mast cells to cysteinyl leukotriene generation and upregulates Toll-like receptor -2 and -4 expression. Int J Immunopathol Pharmacol 23:803-810.
126. Kormann MS, Depner M, Hartl D, Klopp N, Illig T, Adamski J, Vogelberg C, Weiland SK, von Mutius E, and Kabesch M (2008) Toll-like receptor heterodimer variants protect from childhood asthma. J Allergy Clin Immunol 122:86-92, 92.e1-92.e8.
127. Krug N, Madden J, Redington AE, Lackie P, Djukanovic R, Schauer U, Holgate ST, Frew AJ, and Howarth PH (1996) T-cell cytokine profile evaluated at the single cell level in BAL and blood in allergic asthma. Am J Respir Cell Mol Biol 14:319-326.
128. Kulka M, Alexopoulou L, Flavell RA, and Metcalfe DD (2004) Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3. J Allergy Clin Immunol 114:174-182.
129. Kulkarni R, Rampersaud R, Aguilar JL, Randis TM, Kreindler JL, and Ratner AJ (2010) Cigarette smoke inhibits airway epithelial innate immune responses to bacteria. Infect Immun 78:2146-2152.
130. Künzli N, Kaiser R, Medina S, Studnicka M, Chanel O, Filliger P, Herry M, Horak F Jr, Puybonnieux-Texier V, Quénel P, et al. (2000) Public-health impact of outdoor and traffic-related air pollution: a European assessment. Lancet 356:795-801.
131. Laan M, Bozinovski S, and Anderson GP (2004) Cigarette smoke inhibits lipopolysaccharide-induced production of inflammatory cytokines by suppressing the activation of activator protein-1 in bronchial epithelial cells. J Immunol 173:4164-4170.
132. Lacoste JY, Bousquet J, Chanez P, Van Vyve T, Simony-Lafontaine J, Lequeu N, Vic P, Enander I, Godard P, and Michel FB (1993) Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease. J Allergy Clin Immunol 92:537-548.
133. Lambrecht BN (2005) Dendritic cells and the regulation of the allergic immune response. Allergy 60:271-282.
134. Lambrecht BN, De Veerman M, Coyle AJ, Gutierrez-Ramos JC, Thielemans K, and Pauwels RA (2000) Myeloid dendritic cells induce Th2 responses to inhaled antigen, leading to eosinophilic airway inflammation. J Clin Invest 106:551-559.
135. Lambrecht BN, Prins JB, and Hoogsteden HC (2001) Lung dendritic cells and host immunity to infection. Eur Respir J 18:692-704.
136. Lazarus R, Raby BA, Lange C, Silverman EK, Kwiatkowski DJ, Vercelli D, Klimecki WJ, Martinez FD, and Weiss ST (2004) TOLL-like receptor 10 genetic variation is associated with asthma in two independent samples. Am J Respir Crit Care Med 170:594-600.
137. Li N, Harkema JR, Lewandowski RP, Wang M, Bramble LA, Gookin GR, Ning Z, Kleinman MT, Sioutas C, and Nel AE (2010) Ambient ultrafine particles provide a strong adjuvant effect in the secondary immune response: implication for trafficrelated asthma flares. Am J Physiol Lung Cell Mol Physiol 299:L374-L383.
138. Liew FY, Xu D, Brint EK, and O'Neill LA (2005) Negative regulation of toll-like receptor-mediated immune responses. Nat Rev Immunol 5:446-458.
139. Lin E, Freedman JE, and Beaulieu LM (2009) Innate immunity and toll-like receptor antagonists: a potential role in the treatment of cardiovascular diseases. Cardiovasc Ther 27:117-123.
140. Lindquist S (1986) The heat-shock response. Annu Rev Biochem 55:1151-1191.
141. Liu S, Zhou Y, Wang X, Wang D, Lu J, Zheng J, Zhong N, and Ran P (2007a) Biomass fuels are the probable risk factor for chronic obstructive pulmonary disease in rural South China. Thorax 62:889-897.
142. Liu YJ, Soumelis V, Watanabe N, Ito T, Wang YH, Malefyt Rde W, Omori M, Zhou B, and Ziegler SF (2007b) TSLP: an epithelial cell cytokine that regulates T cell differentiation by conditioning dendritic cell maturation. Annu Rev Immunol 25: 193-219.
143. Lombardi V, Van Overtvelt L, Horiot S, Moussu H, Chabre H, Louise A, Balazuc AM, Mascarell L, and Moingeon P (2008) Toll-like receptor 2 agonist Pam3CSK4 enhances the induction of antigen-specific tolerance via the sublingual route. Clin Exp Allergy 38:1819-1829.
144. Lopez AD, Mathers CD, Ezzati M, Jamison DT, and Murray CJ (2006) Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367:1747-1757.
145. Lorenz E, Muhlebach MS, Tessier PA, Alexis NE, Duncan Hite R, Seeds MC, Peden DB, and Meredith W (2008) Different expression ratio of S100A8/A9 and S100A12 in acute and chronic lung diseases. Respir Med 102:567-573.
146. Lotze MT, Zeh HJ, Rubartelli A, Sparvero LJ, Amoscato AA, Washburn NR, Devera ME, Liang X, Tör M, and Billiar T (2007) The grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity. Immunol Rev 220:60-81.
147. Lun SW, Wong CK, Ko FW, Hui DS, and Lam CW (2009) Expression and functional analysis of toll-like receptors of peripheral blood cells in asthmatic patients: implication for immunopathological mechanism in asthma. J Clin Immunol 29: 330-342.
148. MacNee W and Donaldson K (2000) Exacerbations of COPD: environmental mechanisms. Chest 117:390S-397S.
149. Maes T, Bracke KR, Vermaelen KY, Demedts IK, Joos GF, Pauwels RA, and Brusselle GG (2006) Murine TLR4 is implicated in cigarette smoke-induced pulmonary inflammation. Int Arch Allergy Immunol 141:354-368.
150. Mannino DM and Buist AS (2007) Global burden of COPD: risk factors, prevalence, and future trends. Lancet 370:765-773.
151. Månsson A and Cardell LO (2009) Role of atopic status in Toll-like receptor (TLR)7-and TLR9-mediated activation of human eosinophils. J Leukoc Biol 85:719-727.
152. Manzel LJ, Shi L, O'Shaughnessy PT, Thorne PS, and Look DC (2011) Cigarette smoke inhibition of the NF-κB-dependent response to bacteria in the airway. Am J Respir Cell Mol Biol 44:155-165.
153. Marciniak SJ and Lomas DA (2009) What can naturally occurring mutations tell us about the pathogenesis of COPD? Thorax 64:359-364.
154. Marenholz I, Heizmann CW, and Fritz G (2004) S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature). Biochem Biophys Res Commun 322:1111-1122.
155. Marshak-Rothstein A (2006) Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol 6:823-835.
156. Matsushima H, Yamada N, Matsue H, and Shimada S (2004) TLR3-, TLR7-, and TLR9-mediated production of proinflammatory cytokines and chemokines from murine connective tissue type skin-derived mast cells but not from bone marrowderived mast cells. J Immunol 173:531-541.
157. Mattson JD, Haus BM, Desai B, Ott W, Basham B, Agrawal M, Ding W, Hildemann LM, Abitorabi KM, Canfield J, et al. (2008) Enhanced acute responses in an experimental exposure model to biomass smoke inhalation in chronic obstructive pulmonary disease. Exp Lung Res 34:631-662.
158. Mbow ML and Sarisky RT (2005) Modulating toll-like receptor signalling as a novel antiinfective approach. Drug News Perspect 18:179-184.
159. McCurdy JD, Lin TJ, and Marshall JS (2001) Toll-like receptor 4-mediated activation of murine mast cells. J Leukoc Biol 70:977-984.
160. Medzhitov R, Preston-Hurlburt P, and Janeway CA Jr (1997) A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388: 394-397.
161. Møller-Larsen S, Nyegaard M, Haagerup A, Vestbo J, Kruse TA, and Børglum AD (2008) Association analysis identifies TLR7 and TLR8 as novel risk genes in asthma and related disorders. Thorax 63:1064-1069.
162. Mortaz E, Adcock IM, Ito K, Kraneveld AD, Nijkamp FP, and Folkerts G (2010) Cigarette smoke induces CXCL8 production by human neutrophils via activation of TLR9 receptor. Eur Respir J 36:1143-1154.
163. Mortaz E, Kraneveld AD, Smit JJ, Kool M, Lambrecht BN, Kunkel SL, Lukacs NW, Nijkamp FP, and Folkerts G (2009a) Effect of cigarette smoke extract on dendritic cells and their impact on T-cell proliferation. PLoS One 4:e4946.
164. Mortaz E, Lazar Z, Koenderman L, Kraneveld AD, Nijkamp FP, and Folkerts G (2009b) Cigarette smoke attenuates the production of cytokines by human plasmacytoid dendritic cells and enhances the release of IL-8 in response to TLR-9 stimulation. Respir Res 10:47.
165. Mortimer KM, Neas LM, Dockery DW, Redline S, and Tager IB (2002) The effect of air pollution on inner-city children with asthma. Eur Respir J 19:699-705.
166. Mrabet-Dahbi S, Metz M, Dudeck A, Zuberbier T, and Maurer M (2009) Murine mast cells secrete a unique profile of cytokines and prostaglandins in response to distinct TLR2 ligands. Exp Dermatol 18:437-444.
167. Muzio M, Bosisio D, Polentarutti N, D'amico G, Stoppacciaro A, Mancinelli R, van't Veer C, Penton-Rol G, Ruco LP, Allavena P, et al. (2000) Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J Immunol 164:5998-6004.
168. Nel AE, Diaz-Sanchez D, Ng D, Hiura T, and Saxon A (1998) Enhancement of allergic inflammation by the interaction between diesel exhaust particles and the immune system. J Allergy Clin Immunol 102:539-554.
169. NHLBI Workshop (1985) The definition of emphysema. Report of a National Heart, Lung, and Blood Institute, Division of Lung Diseases workshop. Am Rev Respir Dis 132:182-185.
170. Noble PW and Jiang D (2006) Matrix regulation of lung injury, inflammation, and repair: the role of innate immunity. Proc Am Thorac Soc 3:401-404.
171. O'Neill LA (2005) TLRs play good cop, bad cop in the lung. Nat Med 11:1161-1162.
172. Oppenheim JJ and Yang D (2005) Alarmins: chemotactic activators of immune responses. Curr Opin Immunol 17:359-365.
173. Orie NG, Sluiter HJ, Vries K, Tammeling G, and Witkop J (1961) The host factor in bronchitis, in Bronchitis: an International Royal Symposium (Orie NG and Sluiter HJ eds) pp 43-59; 27-29 Apr 1960; Royal Van Gorcum, Assen, The Netherlands.
174. Ormstad H, Johansen BV, and Gaarder PI (1998) Airborne house dust particles and diesel exhaust particles as allergen carriers. Clin Exp Allergy 28:702-708.
175. Orozco-Levi M, Garcia-Aymerich J, Villar J, Ramírez-Sarmiento A, Antó JM, and Gea J (2006) Wood smoke exposure and risk of chronic obstructive pulmonary disease. Eur Respir J 27:542-546.
176. Ospelt C and Gay S (2010) TLRs and chronic inflammation. Int J Biochem Cell Biol 42:495-505.
177. Pace E, Ferraro M, Siena L, Melis M, Montalbano AM, Johnson M, Bonsignore MR, Bonsignore G, and Gjomarkaj M (2008) Cigarette smoke increases Toll-like receptor 4 and modifies lipopolysaccharide-mediated responses in airway epithelial cells. Immunology 124:401-411.
178. Pace E, Giarratano A, Ferraro M, Bruno A, Siena L, Mangione S, Johnson M, and Gjomarkaj M (2011) TLR4 upregulation underpins airway neutrophilia in smokers with chronic obstructive pulmonary disease and acute respiratory failure. Hum Immunol 72:54-62.
179. Pandey S and Agrawal DK (2006) Immunobiology of Toll-like receptors: emerging trends. Immunol Cell Biol 84:333-341.
180. Papakonstantinou E and Karakiulakis G (2009) The 'sweet' and 'bitter' involvement of glycosaminoglycans in lung diseases: pharmacotherapeutic relevance. Br J Pharmacol 157:1111-1127.
181. Papi A, Bellettato CM, Braccioni F, Romagnoli M, Casolari P, Caramori G, Fabbri LM, and Johnston SL (2006) Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med 173:1114-1121.
182. Park JS, Gamboni-Robertson F, He Q, Svetkauskaite D, Kim JY, Strassheim D, Sohn JW, Yamada S, Maruyama I, Banerjee A, et al. (2006) High mobility group box 1 protein interacts with multiple Toll-like receptors. Am J Physiol Cell Physiol 290:C917-C924.
183. Park JS, Svetkauskaite D, He Q, Kim JY, Strassheim D, Ishizaka A, and Abraham E (2004) Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 279:7370-7377.
184. Parkinson T (2008) The future of toll-like receptor therapeutics. Curr Opin Mol Ther 10:21-31.
185. Patel IS, Seemungal TA, Wilks M, Lloyd-Owen SJ, Donaldson GC, and Wedzicha JA (2002) Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax 57:759-764.
186. Patel M, Xu D, Kewin P, Choo-Kang B, McSharry C, Thomson NC, and Liew FY (2005) TLR2 agonist ameliorates established allergic airway inflammation by promoting Th1 response and not via regulatory T cells. J Immunol 174:7558-7563.
187. Pauly JL, Smith LA, Rickert MH, Hutson A, and Paszkiewicz GM (2010) Review: is lung inflammation associated with microbes and microbial toxins in cigarette tobacco smoke? Immunol Res 46:127-136.
188. Pauwels RA (2004) Similarities and differences in asthma and chronic obstructive pulmonary disease exacerbations. Proc Am Thorac Soc 1:73-76.
189. Penders J, Thijs C, van den Brandt PA, Kummeling I, Snijders B, Stelma F, Adams H, van Ree R, and Stobberingh EE (2007) Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study. Gut 56:661-667.
190. Phipps JC, Aronoff DM, Curtis JL, Goel D, O'Brien E, and Mancuso P (2010) Cigarette smoke exposure impairs pulmonary bacterial clearance and alveolar macrophage complement-mediated phagocytosis of Streptococcus pneumoniae. Infect Immun 78:1214-1220.
191. Phipps S, Hansbro N, Lam CE, Foo SY, Matthaei KI, and Foster PS (2009) Allergic sensitization is enhanced in early life through toll-like receptor 7 activation. Clin Exp Allergy 39:1920-1928.
192. Pons J, Sauleda J, Regueiro V, Santos C, Lopez M, Ferrer J, Agusti AG, and Bengoechea JA (2006) Expression of Toll-like receptor 2 is up-regulated in monocytes from patients with chronic obstructive pulmonary disease. Respir Res 7:64.
193. Pope CA, Dockery DW, and Schwartz J (1995) Review of epidemiological evidence of health-effects of particulate air-pollution. Inhal Toxicol 7:1-18.
194. Qiao H, Andrade MV, Lisboa FA, Morgan K, and Beaven MA (2006) FcepsilonR1 and toll-like receptors mediate synergistic signals to markedly augment production of inflammatory cytokines in murine mast cells. Blood 107:610-618.
195. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, et al., and Global Initiative for Chronic Obstructive Lung Disease (2007) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176:532-555.
196. Rahman I and Adcock IM (2006) Oxidative stress and redox regulation of lung inflammation in COPD. Eur Respir J 28:219-242.
197. Rauvala H and Rouhiainen A (2010) Physiological and pathophysiological outcomes of the interactions of HMGB1 with cell surface receptors. Biochim Biophys Acta 1799:164-170.
198. Redecke V, Häcker H, Datta SK, Fermin A, Pitha PM, Broide DH, and Raz E (2004) Cutting edge: activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma. J Immunol 172:2739-2743.
199. Revets H, Pynaert G, Grooten J, and De Baetselier P (2005) Lipoprotein I, a TLR2/4 ligand modulates Th2-driven allergic immune responses. J Immunol 174:1097-1103.
200. Reynolds PR, Cosio MG, and Hoidal JR (2006) Cigarette smoke-induced Egr-1 upregulates proinflammatory cytokines in pulmonary epithelial cells. Am J Respir Cell Mol Biol 35:314-319.
201. Ricciardolo FL, Sterk PJ, Gaston B, and Folkerts G (2004) Nitric oxide in health and disease of the respiratory system. Physiol Rev 84:731-765.
202. Richens TR, Linderman DJ, Horstmann SA, Lambert C, Xiao YQ, Keith RL, Boé DM, Morimoto K, Bowler RP, Day BJ, et al. (2009) Cigarette smoke impairs clearance of apoptotic cells through oxidant-dependent activation of RhoA. Am J Respir Crit Care Med 179:1011-1021.
203. Rifkin IR, Leadbetter EA, Busconi L, Viglianti G, and Marshak-Rothstein A (2005) Toll-like receptors, endogenous ligands, and systemic autoimmune disease. Immunol Rev 204:27-42.
204. Rijkers GT, Bengmark S, Enck P, Haller D, Herz U, Kalliomaki M, Kudo S, Lenoir-Wijnkoop I, Mercenier A, Myllyluoma E, et al. (2010) Guidance for substantiating the evidence for beneficial effects of probiotics: current status and recommendations for future research. J Nutr 140:671S-676S.
205. Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley AM, Corrigan C, Durham SR, and Kay AB (1992) Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 326:298-304.
206. Rock FL, Hardiman G, Timans JC, Kastelein RA, and Bazan JF (1998) A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci USA 95:588-593.
207. Romagne F (2007) Current and future drugs targeting one class of innate immunity receptors: the Toll-like receptors. Drug Discov Today 12:80-87.
208. Roponen M, Yerkovich ST, Hollams E, Sly PD, Holt PG, and Upham JW (2010) Toll-like receptor 7 function is reduced in adolescents with asthma. Eur Respir J 35:64-71.
209. Rubartelli A and Lotze MT (2007) Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox. Trends Immunol 28:429-436.
210. Sabroe I, Dower SK, and Whyte MK (2005) The role of Toll-like receptors in the regulation of neutrophil migration, activation, and apoptosis. Clin Infect Dis 41 (Suppl 7):S421-S426.
211. Sabroe I, Parker LC, Dower SK, and Whyte MK (2008) The role of TLR activation in inflammation. J Pathol 214:126-135.
212. Sabroe I, Whyte MK, Wilson AG, Dower SK, Hubbard R, and Hall I (2004) Toll-like receptor (TLR) 4 polymorphisms and COPD. Thorax 59:81.
213. Sajjan US, Jia Y, Newcomb DC, Bentley JK, Lukacs NW, LiPuma JJ, and Hershenson MB (2006) H. influenzae potentiates airway epithelial cell responses to rhinovirus by increasing ICAM-1 and TLR3 expression. FASEB J 20:2121-2123.
214. Salvi SS and Barnes PJ (2009) Chronic obstructive pulmonary disease in nonsmokers. Lancet 374:733-743.
215. Sapkota AR, Berger S, and Vogel TM (2010) Human pathogens abundant in the bacterial metagenome of cigarettes. Environ Health Perspect 118:351-356.
216. Sarir H, Mortaz E, Janse WT, Givi ME, Nijkamp FP, and Folkerts G (2010) IL-8 production by macrophages is synergistically enhanced when cigarette smoke is combined with TNF-alpha. Biochem Pharmacol 79:698-705.
217. Sarir H, Mortaz E, Karimi K, Kraneveld AD, Rahman I, Caldenhoven E, Nijkamp FP, and Folkerts G (2009) Cigarette smoke regulates the expression of TLR4 and IL-8 production by human macrophages. J Inflamm (Lond) 6:12.
218. Scheibner KA, Lutz MA, Boodoo S, Fenton MJ, Powell JD, and Horton MR (2006) Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J Immunol 177:1272-1281.
219. Schikowski T, Sugiri D, Ranft U, Gehring U, Heinrich J, Wichmann HE, and Krämer U (2005) Long-term air pollution exposure and living close to busy roads are associated with COPD in women. Respir Res 6:152.
220. Schneberger D, Caldwell S, Suri SS, and Singh B (2009) Expression of toll-like receptor 9 in horse lungs. Anat Rec (Hoboken) 292:1068-1077.
221. Schröder NW and Maurer M (2007) The role of innate immunity in asthma: leads and lessons from mouse models. Allergy 62:579-590.
222. Seemungal T, Harper-Owen R, Bhowmik A, Moric I, Sanderson G, Message S, Maccallum P, Meade TW, Jeffries DJ, Johnston SL, et al. (2001) Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164:1618-1623.
223. Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, and Wedzicha JA (1998) Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157:1418-1422.
224. Seong SY and Matzinger P (2004) Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat Rev Immunol 4:469-478.
225. Sethi S, Evans N, Grant BJ, and Murphy TF (2002) New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med 347:465-471.
226. Sethi S and Murphy TF (2008) Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med 359:2355-2365.
227. Sha Q, Truong-Tran AQ, Plitt JR, Beck LA, and Schleimer RP (2004) Activation of airway epithelial cells by toll-like receptor agonists. Am J Respir Cell Mol Biol 31:358-364.
228. Shannon J, Ernst P, Yamauchi Y, Olivenstein R, Lemiere C, Foley S, Cicora L, Ludwig M, Hamid Q, and Martin JG (2008) Differences in airway cytokine profile in severe asthma compared to moderate asthma. Chest 133:420-426.
229. Shoenfelt J, Mitkus RJ, Zeisler R, Spatz RO, Powell J, Fenton MJ, Squibb KA, and Medvedev AE (2009) Involvement of TLR2 and TLR4 in inflammatory immune responses induced by fine and coarse ambient air particulate matter. J Leukoc Biol 86:303-312.
230. Shrestha IL and Shrestha SL (2005) Indoor air pollution from biomass fuels and respiratory health of the exposed population in Nepalese households. Int J Occup Environ Health 11:150-160.
231. Simons FE, Shikishima Y, Van Nest G, Eiden JJ, and HayGlass KT (2004) Selective immune redirection in humans with ragweed allergy by injecting Amb a 1 linked to immunostimulatory DNA. J Allergy Clin Immunol 113:1144-1151.
232. Smith KR (2000) National burden of disease in India from indoor air pollution. Proc Natl Acad Sci USA 97:13286-13293.
233. Smith P, Dunne DW, and Fallon PG (2001) Defective in vivo induction of functional type 2 cytokine responses in aged mice. Eur J Immunol 31:1495-1502.
234. Speletas M, Merentiti V, Kostikas K, Liadaki K, Minas M, Gourgoulianis K, and Germenis AE (2009) Association of TLR4-T399I polymorphism with chronic obstructive pulmonary disease in smokers. Clin Dev Immunol 2009:260286.
235. Stämpfli MR and Anderson GP (2009) How cigarette smoke skews immune responses to promote infection, lung disease and cancer. Nat Rev Immunol 9:377-384.
236. Stowell NC, Seideman J, Raymond HA, Smalley KA, Lamb RJ, Egenolf DD, Bugelski PJ, Murray LA, Marsters PA, Bunting RA, et al. (2009) Long-term activation of TLR3 by poly(I:C) induces inflammation and impairs lung function in mice. Respir Res 10:43.
237. Strachan DP (2000) Family size, infection and atopy: the first decade of the "hygiene hypothesis". Thorax 55 (Suppl 1):S2-S10.
238. Sukkar MB, Xie S, Khorasani NM, Kon OM, Stanbridge R, Issa R, and Chung KF (2006) Toll-like receptor 2, 3, and 4 expression and function in human airway smooth muscle. J Allergy Clin Immunol 118:641-648.
239. Sur S, Wild JS, Choudhury BK, Sur N, Alam R, and Klinman DM (1999) Long term prevention of allergic lung inflammation in a mouse model of asthma by CpG oligodeoxynucleotides. J Immunol 162:6284-6293.
240. Sze M, Gosselink JV, McDonough JE, Elliott M, Adam S, Friedman J, Zhao Y, Varhol R, Miller D, He A, et al. (2011) The lung microbiome in COPD. Am J Respir Crit Care Med 183:A1017.
241. Takano H, Yoshikawa T, Ichinose T, Miyabara Y, Imaoka K, and Sagai M (1997) Diesel exhaust particles enhance antigen-induced airway inflammation and local cytokine expression in mice. Am J Respir Crit Care Med 156:36-42.
242. Takeda K and Akira S (2004) TLR signaling pathways. Semin Immunol 16:3-9.
243. Takeda K, Kaisho T, and Akira S (2003) Toll-like receptors. Annu Rev Immunol 21:335-376.
244. Tanaka J, Watanabe N, Kido M, Saga K, Akamatsu T, Nishio A, and Chiba T (2009) Human TSLP and TLR3 ligands promote differentiation of Th17 cells with a central memory phenotype under Th2-polarizing conditions. Clin Exp Allergy 39:89-100.
245. Tantisira K, Klimecki WT, Lazarus R, Palmer LJ, Raby BA, Kwiatkowski DJ, Silverman E, Vercelli D, Martinez FD, and Weiss ST (2004) Toll-like receptor 6 gene (TLR6): single-nucleotide polymorphism frequencies and preliminary association with the diagnosis of asthma. Genes Immun 5:343-346.
246. Tasaka S, Kamata H, Miyamoto K, Nakano Y, Shinoda H, Kimizuka Y, Fujiwara H, Hasegawa N, Fujishima S, Miyasho T, et al. (2009) Intratracheal synthetic CpG oligodeoxynucleotide causes acute lung injury with systemic inflammatory response. Respir Res 10:84.
247. Tattersfield AE, Postma DS, Barnes PJ, Svensson K, Bauer CA, O'Byrne PM, Löfdahl CG, Pauwels RA, and Ullman A (1999) Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group. Am J Resp Crit Care Med 160:594-599.
248. Taylor KR, Yamasaki K, Radek KA, Di Nardo A, Goodarzi H, Golenbock D, Beutler B, and Gallo RL (2007) Recognition of hyaluronan released in sterile injury involves a unique receptor complex dependent on Toll-like receptor 4, CD44, and MD-2. J Biol Chem 282:18265-18275.
249. Taylor RC, Richmond P, and Upham JW (2006) Toll-like receptor 2 ligands inhibit TH2 responses to mite allergen. J Allergy Clin Immunol 117:1148-1154.
250. Teder P, Vandivier RW, Jiang D, Liang J, Cohn L, Puré E, Henson PM, and Noble PW (2002) Resolution of lung inflammation by CD44. Science 296:155-158.
251. Termeer C, Benedix F, Sleeman J, Fieber C, Voith U, Ahrens T, Miyake K, Freudenberg M, Galanos C, and Simon JC (2002) Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 195:99-111.
252. Tesmer LA, Lundy SK, Sarkar S, and Fox DA (2008) Th17 cells in human disease. Immunol Rev 223:87-113.
253. Tetley TD (2002) Macrophages and the pathogenesis of COPD. Chest 121:156S-159S.
254. Thorley AJ and Tetley TD (2007) Pulmonary epithelium, cigarette smoke, and chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2:409-428.
255. Tirumurugaan KG, Dhanasekaran S, Raj GD, Raja A, Kumanan K, and Ramaswamy V (2010) Differential expression of toll-like receptor mRNA in selected tissues of goat (Capra hircus). Vet Immunol Immunopathol 133:296-301.
256. Tokairin Y, Shibata Y, Sata M, Abe S, Takabatake N, Igarashi A, Ishikawa T, Inoue S, and Kubota I (2008) Enhanced immediate inflammatory response to Streptococcus pneumoniae in the lungs of mice with pulmonary emphysema. Respirology13:324-332.
257. Trupin L, Earnest G, San Pedro M, Balmes JR, Eisner MD, Yelin E, Katz PP, and Blanc PD (2003) The occupational burden of chronic obstructive pulmonary disease. Eur Respir J 22:462-469.
258. Tsan MF and Gao B (2004) Cytokine function of heat shock proteins. Am J Physiol Cell Physiol 286:C739-C744.
259. Tsan MF and Gao B (2009) Heat shock proteins and immune system. J Leukoc Biol 85:905-910.
260. Tulic MK, Fiset PO, Christodoulopoulos P, Vaillancourt P, Desrosiers M, Lavigne F, Eiden J, and Hamid Q (2004) Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response. J Allergy Clin Immunol 113:235-241.
261. Tzortzaki EG and Siafakas NM (2009) A hypothesis for the initiation of COPD. Eur Respir J 34:310-315.
262. Uematsu S and Akira S (2006) Toll-like receptors and innate immunity. J Mol Med 84:712-725.
263. Ulvestad B, Bakke B, Melbostad E, Fuglerud P, Kongerud J, and Lund MB (2000) Increased risk of obstructive pulmonary disease in tunnel workers. Thorax 55: 277-282.
264. Urbonaviciute V, Fürnrohr BG, Meister S, Munoz L, Heyder P, De Marchis F, Bianchi ME, Kirschning C, Wagner H, Manfredi AA, et al. (2008) Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE. J Exp Med 205:3007-3018.
265. van Bergenhenegouwen J, Verheijden KA, Garssen J, Kraneveld AD, and Folkerts G (2011) Bifidobacterium breve and Lactobacillus rhamnosus prevent endotoxininduced lung emphysema in mice. Eur J Pharmacol 668 (Suppl 1): e31-e32.
266. van Vliet P, Knape M, de Hartog J, Janssen N, Harssema H, and Brunekreef B (1997) Motor vehicle exhaust and chronic respiratory symptoms in children living near freeways. Environ Res 74:122-132.
267. van Zoelen MA, Yang H, Florquin S, Meijers JC, Akira S, Arnold B, Nawroth PP, Bierhaus A, Tracey KJ, and van der Poll T (2009) Role of toll-like receptors 2 and 4, and the receptor for advanced glycation end products in high-mobility group box 1-induced inflammation in vivo. Shock 31:280-284.
268. Vandivier RW, Fadok VA, Hoffmann PR, Bratton DL, Penvari C, Brown KK, Brain JD, Accurso FJ, and Henson PM (2002) Elastase-mediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasis. J Clin Invest 109:661-670.
269. Vandivier RW, Henson PM, and Douglas IS (2006) Burying the dead: the impact of failed apoptotic cell removal (efferocytosis) on chronic inflammatory lung disease. Chest 129:1673-1682.
270. Verheijden KA, van Bergenhenegouwen J, Garssen J, Bezemer GF, Kraneveld AD, and Folkerts G (2011) Treatment with specific prebiotics or probiotics prevents the development of lung emphysema in a mouse model of COPD. Eur J Pharmacol 668 (Suppl 1):e12-e13.
271. Vliagoftis H, Kouranos VD, Betsi GI, and Falagas ME (2008) Probiotics for the treatment of allergic rhinitis and asthma: systematic review of randomized controlled trials. Ann Allergy Asthma Immunol 101:570-579.
272. Vollmer J and Krieg AM (2009) Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists. Adv Drug Deliv Rev 61:195-204.
273. Waite DA, Eyles EF, Tonkin SL, and O'Donnell TV (1980) Asthma prevalence in Tokelauan children in two environments. Clin Allergy 10:71-75.
274. Wakashin H, Hirose K, Maezawa Y, Kagami S, Suto A, Watanabe N, Saito Y, Hatano M, Tokuhisa T, Iwakura Y, et al. (2008) IL-23 and Th17 cells enhance Th2-cellmediated eosinophilic airway inflammation in mice. Am J Respir Crit Care Med 178:1023-1032.
275. Wallin RP, Lundqvist A, Moré SH, von Bonin A, Kiessling R, and Ljunggren HG (2002) Heat-shock proteins as activators of the innate immune system. Trends Immunol 23:130-135.
276. Wang JP, Bowen GN, Padden C, Cerny A, Finberg RW, Newburger PE, and Kurt-Jones EA (2008) Toll-like receptor-mediated activation of neutrophils by influenza A virus. Blood 112:2028-2034.
277. Watanabe S, Narisawa Y, Arase S, Okamatsu H, Ikenaga T, Tajiri Y, and Kumemura M (2003) Differences in fecal microflora between patients with atopic dermatitis and healthy control subjects. J Allergy Clin Immunol 111:587-591.
278. Weatherall M, Wijesinghe M, Perrin K, Harwood M, and Beasley R (2010) Metaanalysis of the risk of mortality with salmeterol and the effect of concomitant inhaled corticosteroid therapy. Thorax 65:39-43.
279. Weigt H, Nassenstein C, Tschernig T, Mühlradt PF, Krug N, and Braun A (2005) Efficacy of macrophage-activating lipopeptide-2 combined with interferon-gamma in a murine asthma model. Am J Respir Crit Care Med 172:566-572.
280. Wilde I, Lotz S, Engelmann D, Starke A, van Zandbergen G, Solbach W, and Laskay T (2007) Direct stimulatory effects of the TLR2/6 ligand bacterial lipopeptide MALP-2 on neutrophil granulocytes. Med Microbiol Immunol 196:61-71.
281. Wills-Karp M (2004) Interleukin-13 in asthma pathogenesis. Immunol Rev 202:175-190.
282. Wong JP, Christopher ME, Viswanathan S, Karpoff N, Dai X, Das D, Sun LQ, Wang M, and Salazar AM (2009) Activation of toll-like receptor signaling pathway for protection against influenza virus infection. Vaccine 27:3481-3483.
283. World Health Organization (2001) Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria, Report of a Joint Food and Agriculture Organization of the United Nations/World Health Organization expert consultation; 1-4 Oct 2001; Córdoba, Argentina. Available at: http://www.who.int/foodsafety/publications/fs_management/en/probiotics.pdf.
284. Xu X, Wang H, Wang Z, and Xiao W (2009) Plasminogen activator inhibitor-1 promotes inflammatory process induced by cigarette smoke extraction or lipopolysaccharides in alveolar epithelial cells. Exp Lung Res 35:795-805.
285. Yanagisawa S, Koarai A, Sugiura H, Ichikawa T, Kanda M, Tanaka R, Akamatsu K, Hirano T, Matsunaga K, Minakata Y, et al. (2009) Oxidative stress augments toll-like receptor 8 mediated neutrophilic responses in healthy subjects. Respir Res 10:50.
286. Yang H and Tracey KJ (2010) Targeting HMGB1 in inflammation. Biochim Biophys Acta 1799:149-156.
287. Yang H, Wang H, Czura CJ, and Tracey KJ (2005) The cytokine activity of HMGB1. J Leukoc Biol 78:1-8.
288. Yang H, Wei J, Zhang H, Lin L, Zhang W, and He S (2009) Upregulation of Toll-like receptor (TLR) expression and release of cytokines from P815 mast cells by GMCSF. BMC Cell Biol 10:37.
289. Ying S, O'Connor B, Ratoff J, Meng Q, Mallett K, Cousins D, Robinson D, Zhang G, Zhao J, Lee TH, et al. (2005) Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-attracting chemokines and disease severity. J Immunol 174:8183-8190.
290. Yu M, Wang H, Ding A, Golenbock DT, Latz E, Czura CJ, Fenton MJ, Tracey KJ, and Yang H (2006) HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock 26:174-179.
291. Zaidi AK, Thangam ER, and Ali H (2006) Distinct roles of Ca2+ mobilization and G protein usage on regulation of Toll-like receptor function in human and murine mast cells. Immunology 119:412-420.
292. Zalacain R, Sobradillo V, Amilibia J, Barrón J, Achótegui V, Pijoan JI, and Llorente JL (1999) Predisposing factors to bacterial colonization in chronic obstructive pulmonary disease. Eur Respir J 13:343-348.
293. Zarember KA and Godowski PJ (2002) Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immun 168:554-561.
294. Zhang X, Shan P, Jiang G, Cohn L, and Lee PJ (2006) Toll-like receptor 4 deficiency causes pulmonary emphysema. J Clin Invest 116:3050-3059.
295. Zhang Z and Schluesener HJ (2006) Mammalian toll-like receptors: from endogenous ligands to tissue regeneration. Cell Mol Life Sci 63:2901-2907.
296. Zuany-Amorim C, Hastewell J, and Walker C (2002) Toll-like receptors as potential therapeutic targets for multiple diseases. Nat Rev Drug Discov 1:797-807.